Ken Griffin Pep Gen Inc. Call Options Transaction History
Citadel Advisors LLC
- $618 Billion
- Q3 2025
Call Options
2 transactions
Others Institutions Holding PEPG
# of Institutions
77Shares Held
57.1MCall Options Held
1.14MPut Options Held
103K-
Ra Capital Management, L.P. Boston, MA20.1MShares$95.1 Million1.59% of portfolio
-
Viking Global Investors LP3.48MShares$16.5 Million0.05% of portfolio
-
Commodore Capital LP New York, NY2.36MShares$11.2 Million0.7% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.33MShares$11 Million1.71% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.03MShares$9.62 Million0.02% of portfolio
About PepGen Inc.
- Ticker PEPG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,631,900
- Market Cap $112M
- Description
- PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...